A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate
Clinical trial NCT02698657 · COMPLETED
Trial details
- NCT number
- NCT02698657
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2017-09-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.